Capabilities in Preclinical Parkinson’s Disease Research
PsychoGenics boasts a wide array of capabilities, including the use of transgenic mouse models and advanced tools that uncover the potential impact of your therapy:
Your Preclinical Parkinson’s Disease Research Partner
At PsychoGenics, our comprehensive approach, advanced models, and strategic collaborations drive breakthroughs in preclinical Parkinson’s disease research. Together, let’s change patient outcomes and forge the path to transformative therapies.
Explore our areas of neurodegenerative disease specialization: